{"resourceType": "Composition", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/summary-of-findings"], "versionId": "78", "lastUpdated": "2025-10-21T14:50:13.423Z"}, "identifier": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}], "text": "FEvIR Object Identifier"}, "system": "https://fevir.net/FOI", "value": "236537", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-summary-of-findings-85390-85789", "assigner": {"display": "Computable Publishing LLC"}}], "status": "final", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "SummaryOfFindings", "display": "SummaryOfFindings"}], "text": "Summary of Findings"}, "author": [{"display": "Qiukui Hao"}], "title": "SummaryOfFindings: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "relatesTo": [{"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type", "code": "part-of", "display": "Part Of"}]}, "targetReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"}}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type", "code": "part-of", "display": "Part Of"}]}, "targetReference": {"type": "Composition", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparative-evidence-report-85390-85789", "assigner": {"display": "Computable Publishing LLC"}}, "display": "ComparativeEvidenceSynthesisReport: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Composition/236538"}}, {"type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/artifact-relationship-type", "code": "cite-as", "display": "Cite As"}]}, "targetMarkdown": "SummaryOfFindings: GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Composition Resource]. Contributors: Qiukui Hao [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236537. Revised 2025-10-21. Available at: https://fevir.net/resources/Composition/236537. Computable resource at: https://fevir.net/resources/Composition/236537#json."}], "url": "https://fevir.net/resources/Composition/236537", "date": "2025-10-21T14:50:13.423Z", "custodian": {"reference": "Organization/118079", "type": "Organization", "display": "Computable Publishing LLC"}, "id": "236537", "section": [{"title": "Column Headers", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "column-headers", "display": "Column Headers"}]}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div>"}}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div>"}}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div>"}}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div>"}}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div>"}}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div>"}}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div>"}}], "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"}}, {"title": "Summary of Findings", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings", "display": "Summary of Findings"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "section": [{"title": "All-cause mortality", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313876", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: All-cause mortality", "reference": "EvidenceVariable/236539"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: All-cause mortality</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313876", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: All-cause mortality", "reference": "EvidenceVariable/236539"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>34 studies, 69035 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>12%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: All-cause mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236541"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.7%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: All-cause mortality in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293872"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.71%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: All-cause mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236541"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.29% (-1.83% to -0.64%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of death compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313876-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: All-cause mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236540"}]}]}, {"title": "Cardiovascular mortality", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313877", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Cardiovascular mortality", "reference": "EvidenceVariable/236542"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Cardiovascular mortality</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313877", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Cardiovascular mortality", "reference": "EvidenceVariable/236542"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>20 studies, 63455 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.9%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Cardiovascular mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236544"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Cardiovascular mortality in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293873"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.02%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Cardiovascular mortality in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236544"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.88% (-1.48% to -0.29%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of cardiovascular death compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313877-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Cardiovascular mortality with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236543"}]}]}, {"title": "Nonfatal myocardial infarction", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313878", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Nonfatal myocardial infarction", "reference": "EvidenceVariable/236545"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Nonfatal myocardial infarction</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313878", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Nonfatal myocardial infarction", "reference": "EvidenceVariable/236545"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>32 studies, 67956 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.8%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal myocardial infarction in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236547"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Nonfatal myocardial infarction in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293874"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.02%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal myocardial infarction in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236547"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.78% (-1.47% to -0.1%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of nonfatal myocardial infarction compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313878-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal myocardial infarction with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236546"}]}]}, {"title": "Nonfatal stroke", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313879", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Nonfatal stroke", "reference": "EvidenceVariable/236548"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Nonfatal stroke</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313879", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Nonfatal stroke", "reference": "EvidenceVariable/236548"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>29 studies, 66900 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.8%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236550"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>9.2%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Nonfatal stroke in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293875"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>9.23%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Nonfatal stroke in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236550"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.57% (-2.37% to -0.68%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of nonfatal stroke compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313879-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Nonfatal stroke with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236549"}]}]}, {"title": "End-stage kidney disease", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313880", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: End-stage kidney disease", "reference": "EvidenceVariable/236551"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: End-stage kidney disease</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313880", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: End-stage kidney disease", "reference": "EvidenceVariable/236551"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>4 studies, 10762 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>2%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236553"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.6%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: End-stage kidney disease in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293876"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.57%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: End-stage kidney disease in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236553"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.43% (-0.65% to -0.16%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>High certainty</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>There is no important difference between GLP-1 receptor agonists and standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313880-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: End-stage kidney disease with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236552"}]}]}, {"title": "Heart failure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313881", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Heart failure", "reference": "EvidenceVariable/236554"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Heart failure</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313881", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Heart failure", "reference": "EvidenceVariable/236554"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>13 studies, 46696 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>8%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Heart failure in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236556"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.6%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Heart failure in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293877"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7.56%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Heart failure in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236556"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-0.44% (-1.12% to 0.22%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Moderate certainty -- Due to serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists probably reduce the risk of heart failure compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313881-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Heart failure with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236555"}]}]}, {"title": "Serious hyperglycaemia", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313882", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Serious hyperglycaemia", "reference": "EvidenceVariable/236557"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Serious hyperglycaemia</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313882", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Serious hyperglycaemia", "reference": "EvidenceVariable/236557"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>12 studies, 30066 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>2.5%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236559"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Serious hyperglycaemia in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293878"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>1.02%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Serious hyperglycaemia in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236559"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>-1.48% (-1.86% to -0.89%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>High certainty</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists reduce the risk of serious hyperglycaemia compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313882-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Serious hyperglycaemia with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236558"}]}]}, {"title": "Severe gastrointestinal events", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313883", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Severe gastrointestinal events", "reference": "EvidenceVariable/236560"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Severe gastrointestinal events</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-313883", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Severe gastrointestinal events", "reference": "EvidenceVariable/236560"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>7 studies, 24638 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>4.4%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Severe gastrointestinal events in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236562"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.2%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Severe gastrointestinal events in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293879"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>10.17%</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Severe gastrointestinal events in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236562"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>5.77% (0.92% to 14.22%)</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to inconsistency and serious imprecision.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may increase the risk of severe gastrointestinal events compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-dichotomous-outcome-313883-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Severe gastrointestinal events with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236561"}]}]}, {"title": "Health-related quality of life", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-109569", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Health-related quality of life", "reference": "EvidenceVariable/236563"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Health-related quality of life</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-109569", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Health-related quality of life", "reference": "EvidenceVariable/236563"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No sample size data.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236565"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Health-related quality of life in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293880"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236565"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a difference in proportions.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to very serious imprecision</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may have little or no impact on health-related quality of life.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109569-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Health-related quality of life with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236564"}]}]}, {"title": "Body weight", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-109570", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Body weight", "reference": "EvidenceVariable/236566"}, "section": [{"title": "Outcome", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>OutcomeDefinition: Body weight</p></div>"}, "entry": [{"type": "EvidenceVariable", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-109570", "assigner": {"display": "Computable Publishing LLC"}}, "display": "OutcomeDefinition: Body weight", "reference": "EvidenceVariable/236566"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>60 studies, 44432 participants</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Body weight in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236568"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-intervention-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived InterventionOnlyEvidence: Body weight in GLP-1 RA Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/293881"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparator-only-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived ComparatorOnlyEvidence: Body weight in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236568"}, {"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567"}]}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a difference in proportions.]</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Low certainty -- Due to very serious inconsistency</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>GLP-1 receptor agonists may reduce body weight compared with standard care.</p></div>"}, "entry": [{"type": "Evidence", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-continuous-outcome-109570-comparative-evidence", "assigner": {"display": "Computable Publishing LLC"}}, "display": "MAGIC-derived Evidence: Body weight with GLP-1 RA vs. Standard care in Adults with type 2 diabetes with moderate CV risk", "reference": "Evidence/236567"}]}]}]}]}